MyndTec Wins Ontario Centres of Excellence's (OCE) $20,000 Accessibility Tech Pitch Competition
OBIO® released a report on actionable strategies to establish a world-leading bioscience industry in the province of Ontario.
Toronto, May 1 2017 Conavi Medical Inc. announced their 510(k) clearance from the FDA for its Foresight ICE System expanded feature set.
GAPP is a Genome Canada funding program for Receptors (such as industry, government, not-for-profit, other organizations) working with an academic partner to validate an ‘omics-driven technology.
Expressions of Interest are due to Ontario Genomics on May 15th.
StarFish Medical's 2nd Annual Digital Health Survey
OBIO Member, Focal Healthcare Inc, has been granted a Class II Health Canada Medical Device License for its targeted prostate biopsy device, Fusion Bx
OBIO CAAP 2016 company, Swift Medical, a market leader in machine vision and machine learning platforms for mobile health and data analytics, today announced completing a rounds of funding led by Montreal's Real Ventures with participation from Relay Ventures, Lumira Capital, MaRS IAF and a strategic partner.
OBIO has partnered with JLABS Toronto to provide access to all JLABS Toronto Events for OBIO Members for FREE!
MaRS Innovation (MI) and its South Korean partner, Korea Health Industry Development Institute (KHIDI), continue to build on the five-year global partnership agreement signed in December 2016 during Premier Wynne’s mission to the Republic of Korea.
OBIO CAAP 2014 company, Intronix Technologies, will be launching their "Myoguide DOC"